COLL vs PLD · P/E 17, rev $181.9M vs P/E 27, rev $8.79B
Collegium Pharmaceutical Inc (COLL) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the COLL and PLD stock pages for the full models.
Not investment advice.